Devalued and distrusted: Can the pharmaceutical industry restore its broken image?

Devalued and Distrusted: Can the Pharmaceutical Industry Restore Its Broken Image? offers a balanced view of the role of drug discovery in improving public health.

The author, former Pfizer president John LaMattina addresses the progress that industry has made in improving its abilities to measure both risk and benefits of its new medicines, and then tackles the issue of R&D productivity—the reasons for the drop-off, and how the industry can rehabilitate its image.

Devalued and Distrusted is intended to provide patients, physicians, regulators, and payers with an appreciation of these issues as well as the value that pharmaceutical R&D adds to society.

More information:
Devalued and Distrusted: Can the Pharmaceutical Industry Restore Its Broken Image?
December 2012, 128pp
978-1-1184-8747-1
$22.95; CAN $32.95; €24.60; £20.25

Provided by Wiley